Khorashad, J. S., Wagner, S., Greener, L., Marin, D., Reid, A., Milojkovic, D., Patel, H., Willimott, S., Rezvani, K., Gerrard, G., Loaiza, S., Davis, J., Goldman, J., Melo, J., Apperley, J. and Foroni, L. (2009) “The level of BCR-ABL1 kinase activity before treatment does not identify chronic myeloid leukemia patients who fail to achieve a complete cytogenetic response on imatinib”, Haematologica. Pavia, Italy, 94(6), pp. 861-864. doi: 10.3324/haematol.2008.003715.